Innovent Biologics (HK:1801) has released an update.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Innovent Biologics, Inc. has announced an extraordinary general meeting to be held on June 21, 2024, to approve conditional grants of restricted shares to key executives as part of the 2020 RS Plan. Shareholders will discuss and potentially ratify the allotment and issuance of shares to Dr. De-Chao Michael Yu, Mr. Ronald Hao Xi Ede, and Ms. Joyce I-Yin Hsu, ensuring these shares are on equal footing with existing shares.
For further insights into HK:1801 stock, check out TipRanks’ Stock Analysis page.